Joel Isaacson & Co. LLC Sells 500 Shares of Colgate-Palmolive Company $CL

Joel Isaacson & Co. LLC decreased its position in Colgate-Palmolive Company (NYSE:CL) by 5.4% during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 8,746 shares of the company’s stock after selling 500 shares during the quarter. Joel Isaacson & Co. LLC’s holdings in Colgate-Palmolive were worth $795,000 as of its most recent SEC filing.

A number of other institutional investors also recently modified their holdings of the company. Mraz Amerine & Associates Inc. acquired a new stake in shares of Colgate-Palmolive in the second quarter worth $300,000. KPP Advisory Services LLC grew its stake in shares of Colgate-Palmolive by 12.3% in the second quarter. KPP Advisory Services LLC now owns 11,816 shares of the company’s stock worth $1,074,000 after acquiring an additional 1,293 shares during the last quarter. Relyea Zuckerberg Hanson LLC grew its stake in shares of Colgate-Palmolive by 3.9% in the second quarter. Relyea Zuckerberg Hanson LLC now owns 3,833 shares of the company’s stock worth $348,000 after acquiring an additional 143 shares during the last quarter. Knights of Columbus Asset Advisors LLC grew its stake in shares of Colgate-Palmolive by 3.5% in the second quarter. Knights of Columbus Asset Advisors LLC now owns 42,196 shares of the company’s stock worth $3,836,000 after acquiring an additional 1,411 shares during the last quarter. Finally, Grimes & Company Inc. grew its stake in shares of Colgate-Palmolive by 1.0% in the second quarter. Grimes & Company Inc. now owns 12,495 shares of the company’s stock worth $1,136,000 after acquiring an additional 118 shares during the last quarter. Institutional investors own 80.41% of the company’s stock.

Colgate-Palmolive Stock Up 2.0%

CL opened at $78.99 on Wednesday. Colgate-Palmolive Company has a fifty-two week low of $77.09 and a fifty-two week high of $102.61. The company has a debt-to-equity ratio of 6.79, a current ratio of 0.89 and a quick ratio of 0.57. The firm’s fifty day moving average price is $82.95 and its two-hundred day moving average price is $88.15. The company has a market capitalization of $63.84 billion, a P/E ratio of 22.19, a P/E/G ratio of 4.03 and a beta of 0.34.

Colgate-Palmolive (NYSE:CL) last issued its earnings results on Friday, August 1st. The company reported $0.92 EPS for the quarter, beating the consensus estimate of $0.89 by $0.03. Colgate-Palmolive had a net margin of 14.55% and a return on equity of 377.63%. The company had revenue of $5.11 billion for the quarter, compared to the consensus estimate of $5.03 billion. During the same quarter in the previous year, the company earned $0.91 EPS. The firm’s revenue for the quarter was up 1.0% compared to the same quarter last year. On average, analysts anticipate that Colgate-Palmolive Company will post 3.75 EPS for the current year.

Colgate-Palmolive Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, November 14th. Stockholders of record on Friday, October 17th will be paid a $0.52 dividend. This represents a $2.08 annualized dividend and a dividend yield of 2.6%. The ex-dividend date is Friday, October 17th. Colgate-Palmolive’s payout ratio is currently 58.43%.

Wall Street Analysts Forecast Growth

Several brokerages have recently issued reports on CL. JPMorgan Chase & Co. lowered their price objective on shares of Colgate-Palmolive from $99.00 to $95.00 and set an “overweight” rating on the stock in a research note on Monday, August 4th. Citigroup lowered their price objective on shares of Colgate-Palmolive from $108.00 to $105.00 and set a “buy” rating on the stock in a research note on Monday, August 4th. Wells Fargo & Company lowered their price objective on shares of Colgate-Palmolive from $83.00 to $80.00 and set an “underweight” rating on the stock in a research note on Thursday, September 25th. Morgan Stanley decreased their price target on shares of Colgate-Palmolive from $104.00 to $96.00 and set an “overweight” rating on the stock in a research note on Monday, August 4th. Finally, Barclays decreased their price target on shares of Colgate-Palmolive from $87.00 to $82.00 and set an “equal weight” rating on the stock in a research note on Wednesday, October 1st. Seven analysts have rated the stock with a Buy rating, five have issued a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus price target of $94.83.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.